{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-031559","form_type":"8-K","ticker":"SGMO","cik":"0001001233","company_name":"SANGAMO THERAPEUTICS, INC","filed_at":"2025-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.123334+00:00","generated_at":"2026-05-19T05:53:47.352550+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Sangamo stockholders approve 14M share increase to 2018 equity plan","bullets":["Share reserve increased by 14,000,000 shares; total now includes 8.8M, 9.9M, 7.9M, 10M, 11M from prior years.","Incentive stock option limit raised to 123,200,000 shares.","All nine director nominees elected, including Courtney Beers, Kenneth Hillan, and H. Stewart Parker.","Advisory say-on-pay approved: 32.8M for, 23.2M against, 1.3M abstentions.","Ratification of Ernst & Young as independent auditor for FY2025 passed with 119.6M for."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-031559","json":"https://secwatch.observer/filing/0001628280-25-031559.json","markdown":"https://secwatch.observer/filing/0001628280-25-031559.md","text":"https://secwatch.observer/filing/0001628280-25-031559.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001233/000162828025031559/0001628280-25-031559-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001233/000162828025031559/sgmo-20250612.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T05:53:47.352550+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}